CABA - Cabaletta Bio Inc

https://www.cabalettabio.com

Momentum: Bearish

Recent News

Cabaletta Bio ( CABA ) Upgraded to Buy: Here's Why

Zacks Commentary • 1 month ago • score: 0.36

Cabaletta Bio (CABA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Bullish

Cabaletta Bio to Participate in the Jefferies Global Healthcare Conference

GlobeNewswire • 3 months, 2 weeks ago • score: 0.25

PHILADELPHIA, May 29, 2025 ( GLOBE NEWSWIRE ) -- Cabaletta Bio, Inc. ( Nasdaq: CABA ) , a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies designed specifically for patients with autoimmune diseases, today announced that the ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Downtrend

Source: Snapshot

Cabaletta Bio, Inc., a clinical-stage biotechnology company, focuses on the discovery and development of T-cell therapies designed for patients with B-cell-mediated autoimmune diseases. The company is headquartered in Philadelphia, Pennsylvania.

52W High

$5.46

52W Low

$0.99

MA Status:

50D: Below 200D: Below

Beta (~1 neutral, <0.9 lower risk)

2.85

Valuation

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

N/A

EV/EBITDA (<8 favorable)

-3.44

EV/Revenue (<3 favorable)

N/A

P/S (TTM) (<3 favorable)

N/A

P/B (<3 favorable)

0.87

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

1.66%

Institutions (25–75% balanced)

79.80%

Shares Outstanding

91,465,000

Float

61,645,000

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

Gross Profit (TTM)

EPS (TTM)

-2.71

Profit Margin (>10% good)

N/A

Operating Margin (TTM) (higher better)

N/A

ROE (TTM) (>15% strong)

-0.76%

EPS YoY (Quarterly) (>10% good)

N/A

Revenue YoY (Quarterly) (>8% good)

N/A

Momentum

Bearish momentum

Value

0.0629

0.0464

Trend

Rising

Signal Cross

No cross

As of

Sep. 12, 2025